권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
Contents
Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units : experience in a single hospital in Korea for 6.6 years / Seon-Sook Han ; Jae-Joon Yim ; Chul-Gyu Yoo ; Young Whan Kim ; Sung Koo Han ; Young-Soo Shim ; Sang-Min Lee 1
[요약] 1
Introduction 1
Materials and methods 1
Study design and patients 1
Definitions 2
Matching procedure 2
Statistical analysis 2
Results 2
Analysis of patients with candidemia 2
Comparison of candidemia patients with matched control patients 3
Discussion 4
Acknowledgements 5
References 5
The aim of this study was to determine candidemia incidence among patients in a
medical intensive-care unit (MICU) and the associated mortality rate and to identify
risk factors associated with candidemia. We retrospectively performed a 1:3 matched
case-control study of MICU patients with candidemia. Controls were matched for
sex, age, and Acute Physiology and Chronic Health Evaluation (APACHE) II score.
Candidemia incidence was 9.1 per 1,000 admissions. The most common pathogen
was Candida albicans. Crude mortality was 96% among candidemia patients and
52% among controls (P<0.001). Mortality differed significantly between the groups
according to Kaplan-Meier survival analysis (P=0.024). Multivariate analysis identified
the following independent risk factors for candidemia: central venous catheterization
(odds ratio [OR] = 3.2, 95% confidence interval [CI]=1.2-9.0), previous steroid
therapy (OR=4.7, 95% CI=1.8-12.1), blood transfusion during the same admission
period (OR=6.3, 95% CI=2.4-16.7), and hepatic failure upon MICU admission
(OR=6.9, 95% CI=1.7-28.4). In conclusion, we identify an additional independent risk
factor for candidemia, the presence of hepatic failure on MICU admission. Therefore,
increased awareness of risk factors, including hepatic failure, is necessary for the management
of candidemia.| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Epidemiology of Candida species infections in critically ill non-immunosuppressed patients ![]() |
미소장 |
| 2 | Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2007; 6: 21. | 미소장 |
| 3 | Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study ![]() |
미소장 |
| 4 | A prospective epidemiological survey of candidaemia in Sweden. ![]() |
미소장 |
| 5 | Puzniak L, Teutsch S, Powderly W, Polish L. Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol 2004; 25: 628-33. | 미소장 |
| 6 | Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance ![]() |
미소장 |
| 7 | Alonso-Valle H, Acha O, Garcia-Palomo JD, Farinas-Alvarez C, Fernandez- Mazarrasa C, Farinas MC. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003; 22: 254-7. | 미소장 |
| 8 | An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait ![]() |
미소장 |
| 9 | Attributable Mortality of Nosocomial Candidemia, Revisited ![]() |
미소장 |
| 10 | Factors Associated with the Development of Candidemia and Candidemia-Related Death Among Liver Transplant Recipients ![]() |
미소장 |
| 11 | Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997 ![]() |
미소장 |
| 12 | Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy ![]() |
미소장 |
| 13 | Epidemiology and the Internet ![]() |
미소장 |
| 14 | Managing the challenges of invasive fungal infections. ![]() |
미소장 |
| 15 | A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects ![]() |
미소장 |
| 16 | APACHE II: a severity of disease classification system. ![]() |
미소장 |
| 17 | Effects of nosocomial candidemia on outcomes of critically ill patients ![]() |
미소장 |
| 18 | Risk Factors for the Development of Nosocomial Candidemia among Patients in Intensive Care Unit. | 소장 |
| 19 | Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospitalacquired candidemia. The attributable mortality and excess length stay. Arch Intern Med 1998; 148: 2642-5. | 미소장 |
| 20 | The changing epidemiology of invasive fungal infections: new threats. ![]() |
미소장 |
| 21 | Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case control studies. Eur J Clin Microbiol Infect Dis 2006; 25: 419-25. | 미소장 |
| 22 | Fungal infection: a common, unrecognised complication of acute liver failure ![]() |
미소장 |
| 23 | Bacterial and fungal infection in acute liver failure. ![]() |
미소장 |
| 24 | Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. ![]() |
미소장 |
| 25 | Fungal colonisation and fluconazole therapy in acute liver disease. ![]() |
미소장 |
| 26 | Impaired Function of Macrophage Fcγ Receptors and Bacterial Infection in Alcoholic Cirrhosis ![]() |
미소장 |
| 27 | Macrophage function in cirrhosis and the risk of bacterial infection. ![]() |
미소장 |
| 28 | Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. ![]() |
미소장 |
| 29 | Times to detection of bacteria and yeasts in BACTEC 9240 blood culture bottles. ![]() |
미소장 |
| 30 | Saito T, Senda K, Takakura S, Fujihara N, Kudo T, Iinuma Y, Tanimoto M, Ichiyama S. Detection of bacteria and fungi in BacT/Alert standard blood-culture bottles. J Infect Chemother 2003; 9: 227-32. | 미소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내17
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.